TSS Named a Di Gasell 2025

A person wearing blue gloves and a lab coat is handling a large metal plate, partially immersing it into an industrial liquid tank in a laboratory.
We’re proud to share that TSS has been recognized as a Di Gasell 2025, an award from the national financial newspaper Dagens industri celebrating Sweden’s fastest-growing and most successful companies.

The Di Gasell recognition highlights companies that demonstrate strong, sustainable, and organic growth while maintaining financial stability and a solid business foundation. Each year, only a small percentage of Swedish companies meet the high standards required to become a Gasell.

“This milestone is a testament to our dedication, innovation, and teamwork at TSS. Every one of us has contributed to this achievement, from developing progressive solutions to supporting our customers. It truly shows what we can accomplish together,” says Tobias Holmer, CEO of TSS.

This recognition reflects the continued growth of TSS as a trusted partner in automated temperature monitoring and data-driven compliance for the life science supply chain. It also highlights the collective effort of our teams—driving innovation, delivering customer value, and ensuring product integrity at every stage of the supply chain.

Being named a Di Gasell is more than a financial achievement—it’s a recognition of resilience, collaboration, and purpose. At TSS, we’re proud to grow together with our customers and partners as we continue shaping the future of temperature monitoring.

You may also be interested in

Covid-19 situation

The effects of the Covid-19 outbreak are escalating daily and is first and foremost a human tragedy, affecting hundreds of thousands of people.
Read moreDownload Whitepaper

Exploring the solution to a global question

When it comes to global transportation and shipping of drugs, simply knowing where they are is no longer enough. Pharmaceutical organisations are becoming increasingly aware of the safety regulations which go into storage and transportation, i.e. ensuring that every drug which reaches the patient end, is effective and safe for consumption.
Read moreDownload Whitepaper

New opportunities on the horizon as TSS expands US operations

We are expanding our US operations, with Evan Hahn to be the new VP North America. Evan brings a wealth of knowledge of the pharmaceutical clinical trial space, supporting the TSS launch of its new offering in this category.
Read moreDownload Whitepaper

You may also be interested in

Can You Rely on the Results from Your Clinical Trials?

The success of a clinical trial depends on the reliability of its data. Many investigational drugs are sensitive to temperature, and any temperature deviation can affect their quality and, in the worst case, patient safety. Automated and integrated temperature monitoring solutions help secure data quality, support compliance, and speed up the delivery of new medicines to patients.
Read more

Extending TempMonitor BLE to Ultra-Low Temperatures

Introducing the new TSS Dry Ice Probes, enginereed for accurate and GxP-compliant temperature monitoring down to –90°C. Available in two lengths for flexible setup — built to safeguard product integrity in every environment.
Read more

Subscribe to our newsletter

Sign up for our newsletter to receive all the latest TSS news and insights in temperature management solutions.